Aligos Therapeutics, Inc.
ALGS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001799448
No open-market purchases or sales by Aligos Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $13.2M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
13F holders, Q3 2021
Institutional positions in Aligos Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 68
- +10 vs. Q2 2021
- Shares held
- 31.2M
- +4.19M (+15.5%) vs. Q2 2021
- Total value
- $483.9M
- −$66.6M (−12.1%) vs. Q2 2021
- New holders
- 16
- 30 more added
- Sold out
- 6
- 10 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALGS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $13.2M |
| Q1 2026 | 35 | $20.6M |
| Q4 2025 | 41 | $26.2M |
| Q3 2025 | 33 | $26.0M |
| Q2 2025 | 37 | $19.5M |
| Q1 2025 | 35 | $27.1M |
| Q4 2024 | 34 | $64.5M |
| Q3 2024 | 27 | $14.7M |
| Q2 2024 | 49 | $16.6M |
| Q1 2024 | 49 | $45.3M |
| Q4 2023 | 40 | $30.1M |
| Q3 2023 | 36 | $19.2M |
| Q2 2023 | 41 | $25.5M |
| Q1 2023 | 46 | $23.9M |
| Q4 2022 | 39 | $25.3M |
| Q3 2022 | 52 | $30.4M |
| Q2 2022 | 60 | $36.0M |
| Q1 2022 | 76 | $68.4M |
| Q4 2021 | 71 | $390.4M |
| Q3 2021 | 68 | $483.9M |
| Q2 2021 | 58 | $550.5M |
| Q1 2021 | 52 | $612.4M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Aligos Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wellington Management Group LLP | 3,829,383 | $59.4M | 0.01% | −346,198−8.3% | Reduced |
| Vivo Capital, LLC | 3,547,030 | $55.0M | 2.47% | 00.0% | Unchanged |
| Novo Holdings A/S | 2,614,563 | $40.6M | 2.10% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 2,440,476 | $37.7M | 0.02% | +180,709+8.0% | Added |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 2,365,064 | $36.7M | 0.48% | +200,000+9.2% | Added |
| Versant Venture Management, LLC | 2,320,381 | $36.0M | 14.90% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 2,076,400 | $32.2M | 0.14% | +466,400+29.0% | Added |
| Logos Global Management LP | 1,962,785 | $30.4M | 2.20% | +1,750,000+822.4% | Added |
| Boxer Capital, LLC | 1,526,048 | $23.7M | 0.83% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 1,475,000 | $22.9M | 0.04% | +975,000+195.0% | Added |
| Vanguard Group Inc | 1,275,215 | $19.8M | 0.00% | +291,919+29.7% | Added |
| BlackRock Inc. | 1,239,562 | $19.2M | 0.00% | +155,518+14.3% | Added |
| Pivotal bioVenture Partners Investment Advisor LLC | 876,548 | $13.6M | 4.80% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 667,167 | $10.3M | 0.42% | −238,300−26.3% | Reduced |
| Morgan Stanley | 469,404 | $7.28M | 0.00% | +453,545+2,859.9% | Added |
| State Street Corp | 374,232 | $5.80M | 0.00% | +75,645+25.3% | Added |
| Geode Capital Management, LLC | 313,655 | $4.86M | 0.00% | +58,307+22.8% | Added |
| Sphera Funds Management Ltd. | 249,197 | $3.87M | 0.38% | +249,197 | New |
| Northern Trust Corp | 198,311 | $3.08M | 0.00% | +20,297+11.4% | Added |
| Charles Schwab Investment Management Inc | 135,330 | $2.10M | 0.00% | +46,291+52.0% | Added |
| Sofinnova Investments, Inc. | 124,342 | $1.93M | 0.12% | −39,709−24.2% | Reduced |
| Norges Bank | 102,400 | $1.59M | 0.00% | +102,400 | New |
| Point72 Asset Management, L.P. | 97,300 | $1.51M | 0.01% | +97,300 | New |
| Two Sigma Investments, LP | 89,863 | $1.39M | 0.00% | +89,863 | New |
| Nuveen Asset Management, LLC | 88,224 | $1.37M | 0.00% | +24,008+37.4% | Added |
| Deutsche Bank AG | 83,752 | $1.30M | 0.00% | −12,739−13.2% | Reduced |
| Millennium Management LLC | 69,943 | $1.08M | 0.00% | +69,943 | New |
| Swiss National Bank | 56,200 | $872.0K | 0.00% | +22,600+67.3% | Added |
| Renaissance Technologies LLC | 53,200 | $825.0K | 0.00% | +53,200 | New |
| Bank of New York Mellon Corp | 48,501 | $752.0K | 0.00% | +3,080+6.8% | Added |
| Bank of America Corp | 33,729 | $522.0K | 0.00% | +16,985+101.4% | Added |
| Altium Capital Management LP | 33,492 | $519.0K | 0.14% | +33,492 | New |
| California State Teachers Retirement System | 32,126 | $498.0K | 0.00% | +6,236+24.1% | Added |
| Price T Rowe Associates Inc | 27,279 | $423.0K | 0.00% | +49+0.2% | Added |
| State of Wisconsin Investment Board | 24,300 | $377.0K | 0.00% | +3,575+17.2% | Added |
| Goldman Sachs Group Inc | 23,737 | $368.0K | 0.00% | −14,231−37.5% | Reduced |
| HarbourVest Partners LLC | 18,783 | $291.0K | 0.03% | 00.0% | Unchanged |
| Sectoral Asset Management Inc | 16,908 | $262.0K | 0.02% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 16,500 | $256.0K | 0.00% | +16,500 | New |
| New York State Common Retirement Fund | 16,300 | $253.0K | 0.00% | +102+0.6% | Added |
| Algert Global LLC | 16,146 | $250.0K | 0.03% | +16,146 | New |
| Jump Financial, LLC | 16,100 | $250.0K | 0.02% | +16,100 | New |
| JPMorgan Chase & Co | 15,684 | $244.0K | 0.00% | −10,225−39.5% | Reduced |
| ETF Managers Group, LLC | 15,558 | $236.0K | 0.00% | +4,304+38.2% | Added |
| Golden State Wealth Management, LLC | 14,860 | $230.0K | 0.05% | 00.0% | Unchanged |
| Rhumbline Advisers | 13,599 | $211.0K | 0.00% | +1,059+8.4% | Added |
| Credit Suisse AG | 13,624 | $211.0K | 0.00% | +13,624 | New |
| Manufacturers Life Insurance Company, The | 12,276 | $190.0K | 0.00% | +1,192+10.8% | Added |
| American International Group, Inc. | 11,558 | $179.0K | 0.00% | +1,045+9.9% | Added |
| SG Americas Securities, LLC | 8,383 | $130.0K | 0.00% | +8,383 | New |
| MetLife Investment Management | 8,308 | $128.9K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 7,822 | $121.0K | 0.00% | +5,175+195.5% | Added |
| Virtus ETF Advisers LLC | 6,814 | $106.0K | 0.05% | −353−4.9% | Reduced |
| Metropolitan Life Insurance Co | 6,507 | $100.9K | 0.00% | +146+2.3% | Added |
| Hershey Trust Co | 6,063 | $94.0K | 0.00% | 00.0% | Unchanged |
| Macquarie Group Ltd | 5,786 | $90.0K | 0.00% | +5,786 | New |
| Advisor Group Holdings, Inc. | 4,500 | $70.0K | 0.00% | +4,500 | New |
| O'Shaughnessy Asset Management, LLC | 3,261 | $51.0K | 0.00% | +3,261 | New |
| Citigroup Inc | 3,122 | $48.0K | 0.00% | +1,037+49.7% | Added |
| Royal Bank of Canada | 1,768 | $27.0K | 0.00% | +484+37.7% | Added |
| Ameritas Investment Partners, Inc. | 1,471 | $23.0K | 0.00% | 00.0% | Unchanged |
| Point72 Hong Kong Ltd | 1,357 | $21.0K | 0.00% | +1,357 | New |
| Tower Research Capital LLC (TRC) | 873 | $14.0K | 0.00% | −593−40.5% | Reduced |
| UBS Group AG | 728 | $11.0K | 0.00% | +377+107.4% | Added |
| US Bancorp | 413 | $6.00K | 0.00% | +394+2,073.7% | Added |
| Evolution Wealth Advisors, LLC | 194 | $3.00K | 0.00% | −123−38.8% | Reduced |
| State of Wyoming | 91 | $1.00K | 0.00% | −44−32.6% | Reduced |
| Newbridge Financial Services Group, Inc. | 37 | $1.00K | 0.00% | 00.0% | Unchanged |
| VR Adviser, LLC | 0 | $0 | 0.00% | −408,377−100.0% | Sold out |
| Acuta Capital Partners, LLC | 0 | $0 | 0.00% | −214,254−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −24,889−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −16,355−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −15,237−100.0% | Sold out |
| Hamilton Lane Advisors LLC | 0 | $0 | 0.00% | −12,127−100.0% | Sold out |